Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Kiernan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Virology|November 13, 1998
Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutationsR E Kiernan, E O Freed
Journal of Virology|May 11, 1999
Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivityR E Kiernan, A Ono, E O Freed
Journal of Virological Methods|December 1, 1988
Quantitation of infectious human immunodeficiency virus using a modified plaque forming assayR E Kiernan, D A McPhee, R R Doherty
Journal of Virology|April 29, 1998
Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycleR E Kiernan, A Ono, G Englund, et al.
Archives of Virology|January 1, 1987
Cellular changes associated with persistent hepatitis A infection in vitroR E Kiernan, J A Marshall, A G Coulepis, et al.
Journal of Leukocyte Biology|September 1, 1994
Accumulation of unintegrated circular viral DNA in monocytes and growth-arrested T cells following infection with HIV-1S Sonza, R E Kiernan, A L Maerz, et al.
Molecular and Cellular Biology|November 2, 2001
Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasomeR E Kiernan, S Emiliani, K Nakayama, et al.
Journal of Virological Methods|June 1, 1992
A new electron microscope positive staining method for viruses in suspensionJ C Doultree, R E Kiernan, J Y Lee, et al.
The EMBO Journal|November 2, 1999
HIV-1 tat transcriptional activity is regulated by acetylationR E Kiernan, C Vanhulle, L Schiltz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Virology|November 13, 1998
Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutationsR E Kiernan, E O Freed
Journal of Virology|May 11, 1999
Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivityR E Kiernan, A Ono, E O Freed
Journal of Virological Methods|December 1, 1988
Quantitation of infectious human immunodeficiency virus using a modified plaque forming assayR E Kiernan, D A McPhee, R R Doherty
Journal of Virology|April 29, 1998
Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycleR E Kiernan, A Ono, G Englund, et al.
Archives of Virology|January 1, 1987
Cellular changes associated with persistent hepatitis A infection in vitroR E Kiernan, J A Marshall, A G Coulepis, et al.
Journal of Leukocyte Biology|September 1, 1994
Accumulation of unintegrated circular viral DNA in monocytes and growth-arrested T cells following infection with HIV-1S Sonza, R E Kiernan, A L Maerz, et al.
Molecular and Cellular Biology|November 2, 2001
Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasomeR E Kiernan, S Emiliani, K Nakayama, et al.
Journal of Virological Methods|June 1, 1992
A new electron microscope positive staining method for viruses in suspensionJ C Doultree, R E Kiernan, J Y Lee, et al.
The EMBO Journal|November 2, 1999
HIV-1 tat transcriptional activity is regulated by acetylationR E Kiernan, C Vanhulle, L Schiltz, et al.
Pageof 1